dc.creatorFaúndes, A
dc.creatorFiala, C
dc.creatorTang, O S
dc.creatorVelasco, A
dc.date2007-Dec
dc.date2015-11-27T13:10:35Z
dc.date2015-11-27T13:10:35Z
dc.date.accessioned2018-03-29T01:05:41Z
dc.date.available2018-03-29T01:05:41Z
dc.identifierInternational Journal Of Gynaecology And Obstetrics: The Official Organ Of The International Federation Of Gynaecology And Obstetrics. v. 99 Suppl 2, p. S172-7, 2007-Dec.
dc.identifier0020-7292
dc.identifier10.1016/j.ijgo.2007.09.006
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/17961570
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/197517
dc.identifier17961570
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1297750
dc.descriptionThe aim was to review the current knowledge about the use of misoprostol alone for abortion induction during the first 12 weeks of pregnancy. Publications reporting experiences with misoprostol alone for pregnancy termination within the first 12 weeks of pregnancy were included in the analysis. Vaginal administration of 800 microg repeated up to three times at 6, 12 or 24 h intervals has an 85% to 90% effectiveness, defined as complete abortion, in most studies. Oral administration is less effective, but sublingual administration at 3-hour interval has the same effectiveness, with more frequent side effects. The oral and sublingual routes appear to be better accepted than vaginal administration. Most studies are limited to the first 9 weeks of pregnancy. The experience on pregnancy termination between 10 and 12 weeks is not yet sufficient for a recommendation.
dc.description99 Suppl 2
dc.descriptionS172-7
dc.languageeng
dc.relationInternational Journal Of Gynaecology And Obstetrics: The Official Organ Of The International Federation Of Gynaecology And Obstetrics
dc.relationInt J Gynaecol Obstet
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAbortifacient Agents, Nonsteroidal
dc.subjectAbortion, Therapeutic
dc.subjectDrug Administration Routes
dc.subjectDrug Administration Schedule
dc.subjectFemale
dc.subjectHumans
dc.subjectMisoprostol
dc.subjectPregnancy
dc.subjectPregnancy Trimester, First
dc.subjectTreatment Outcome
dc.titleMisoprostol For The Termination Of Pregnancy Up To 12 Completed Weeks Of Pregnancy.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución